Overview
ISO 11607-2:2019/Amd 1:2023 is an important amendment to the international standard ISO 11607-2:2019, which specifies the validation requirements for forming, sealing, and assembly processes involved in packaging for terminally sterilized medical devices. This 2023 amendment integrates the application of risk management into the framework, emphasizing a structured approach to identifying, evaluating, and controlling risks related to packaging processes.
This standard is published by the International Organization for Standardization (ISO) and serves as a critical guideline for manufacturers, healthcare organizations, and regulatory bodies to ensure the safety, sterility, and integrity of medical device packaging. The inclusion of risk management aligns packaging validation activities with overall medical device safety requirements and regulatory expectations.
Key Topics
-
Risk Management Integration
The amendment introduces a comprehensive process for risk management compliant with Annex B. This process extends through all phases of packaging formation-from design and validation to production and post-production monitoring-focusing on the reduction of potential hazards to users and patients.
-
Hazard Identification
Identification and assessment of dangerous phenomena, such as microbial contamination, chemical contamination, environmental and process conditions, and misleading information, are essential to predict and prevent failure modes in packaging processes.
-
Risk Estimation and Evaluation
The standard requires estimating risks based on both the probability of occurrence and the severity of potential damage. Risks are then compared against defined acceptability criteria to determine necessary control measures.
-
Risk Control Measures
Emphasis is placed on a hierarchical approach to risk control:
- Design process improvements to eliminate or reduce risks,
- Implementation of control tools, alarms, and process monitoring,
- Training operators and providing information about possible failure modes.
-
Continuous Monitoring and Review
The effectiveness of risk control measures must be regularly evaluated, especially when deviations occur during process validation or routine production, ensuring continuous compliance and product safety.
-
Documentation and Planning
Risk management activities must be documented through a risk management plan specifying the scope, risk acceptability criteria, and verification methods to ensure regulatory and quality compliance.
Applications
ISO 11607-2:2019/Amd 1:2023 is designed for application by:
-
Medical Device Manufacturers
To validate and document the forming, sealing, and assembly processes of sterile barrier systems (SBS), ensuring sterile packaging integrity throughout product shelf life and use.
-
Quality and Regulatory Professionals
To align packaging process validation with risk management principles, meeting regulatory requirements related to medical device packaging safety in jurisdictions worldwide.
-
Healthcare Organizations
Supporting procurement and inspection of sterile medical devices by understanding packaging validation and risk management standards.
-
Suppliers of Packaging Equipment and Materials
To develop and qualify equipment and materials that conform to risk-managed validation requirements which reduce contamination and other packaging-related risks.
The standard facilitates safer medical device packaging solutions, reduces risks of contamination, and ensures sterility assurance-key goals in healthcare and patient safety.
Related Standards
- ISO 11607-1:2019 and its Amendment 1:2023 – Specifies requirements for packaging materials, systems, and sterilized barrier system design.
- ISO 14971:2019 – The international standard detailing risk management principles specifically for medical devices.
- ISO/TR 24971:2020 – Provides guidance on applying ISO 14971 and complements risk management practices for medical devices.
- ISO 9000:2015 – Defines essential quality management and process terminology that supports implementation of process controls.
- ISO/IEC 63:2019 – Guides hazard and risk definitions that underpin risk management processes within ISO 11607-2.
By harmonizing risk management principles from ISO 14971 with specific packaging process controls, ISO 11607-2:2019/Amd 1:2023 advances the reliability and safety of terminally sterilized medical device packaging, supporting regulatory compliance and enhancing patient protection across the medical device lifecycle.
Keywords: ISO 11607-2:2019 Amendment 1, sterile medical device packaging, validation requirements, risk management, forming and sealing processes, sterile barrier system, medical device packaging standards, contamination control, packaging process validation, ISO risk management, packaging validation healthcare.
Open preview (PDF)Packaging for terminally sterilized medical devices — Part 2: Validation requirements for forming, sealing and assembly processes — Amendment 1: Application of risk management
